FranΓ§ais| Sector | Profitable calls | Avg gain / call | Calls |
|---|---|---|---|
| Crypto | 61.1% | +65% | 18 |
| Health Care | 41.5% | +7% | 53 |
| Stock | Profitable calls | Avg gain / call | Calls |
|---|---|---|---|
| Coinbase (COIN) | 68.8% | +80% | 16 |
| Vertex Pharmaceuticals (VRTX) | 57.7% | +16% | 26 |
| Regeneron Pharmaceuticals (REGN) | 40% | +14% | 5 |
| Biogen (BIIB) | 22.7% | -5% | 22 |
β See the full analyst leaderboard
In short β Over 1 year, 46.5% of HC Wainwright & Co.'s targets turned out profitable, for an average gain of +22% per call (i.e. +6% vs its sector), across 71 timestamped calls replayed against real prices. JPI verdict: mixed reliability. An analyst can be good in one sector and poor in another β details below.
Ses secteurs les plus fiables : Crypto (61.1% profitables, +65% / call), Health Care (41.5% profitables, +7% / call).
71 timestamped HC Wainwright & Co. targets were replayed against real prices over 1 year β the basis for the 46.5% profitable-calls figure.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best β on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
Explore JPI Invest for free β How it works: the method β
β οΈ Educational, not advice. Β« Reliability Β» = past targets replayed against real prices (point-in-time). Past performance does not predict the future.